Publications by authors named "Dan Prelusky"

Claim this Profile
A
Aurora kinase inhibitors based on the imidazo[1,2-a]pyrazine core: fluorine and deuterium incorporation improve oral absorption and exposure.
Angela D Kerekes, Sara J Esposite, Ronald J Doll, Jayaram R Tagat, Tao Yu, Dan B Prelusky

J Med Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors.
David B Belanger, Michael J Williams, Patrick J Curran, Amit K Mandal, Zhaoyang Meng, Dan B Prelusky

Bioorg Med Chem Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of a potent and selective inhibitor of PDE4 for inhaled administration.
Richard W Chapman, Aileen House, Jennifer Richard, Dan Prelusky, James Lamca

Eur J Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Tongtong Liu, Lee-Jah Chang, Annette Uss, Inhou Chu, Richard A Morrison, Dan Prelusky

J Pharm Biomed Anal· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
Richard W Chapman, Aileen House, Howard Jones, Jennifer Richard, Chander Celly, Dan Prelusky

Eur J Pharmacol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis